EP1084142A4 - Gpr35a-rezeptor - Google Patents

Gpr35a-rezeptor

Info

Publication number
EP1084142A4
EP1084142A4 EP99955477A EP99955477A EP1084142A4 EP 1084142 A4 EP1084142 A4 EP 1084142A4 EP 99955477 A EP99955477 A EP 99955477A EP 99955477 A EP99955477 A EP 99955477A EP 1084142 A4 EP1084142 A4 EP 1084142A4
Authority
EP
European Patent Office
Prior art keywords
gpr35a
receptor
gpr35a receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99955477A
Other languages
English (en)
French (fr)
Other versions
EP1084142A1 (de
Inventor
Nabil A Elshourbagy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1084142A1 publication Critical patent/EP1084142A1/de
Publication of EP1084142A4 publication Critical patent/EP1084142A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP99955477A 1998-06-11 1999-06-01 Gpr35a-rezeptor Withdrawn EP1084142A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9603198A 1998-06-11 1998-06-11
US96031 1998-06-11
PCT/US1999/012123 WO1999064452A1 (en) 1998-06-11 1999-06-01 Gpr35a receptor

Publications (2)

Publication Number Publication Date
EP1084142A1 EP1084142A1 (de) 2001-03-21
EP1084142A4 true EP1084142A4 (de) 2005-01-19

Family

ID=22254823

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99955477A Withdrawn EP1084142A4 (de) 1998-06-11 1999-06-01 Gpr35a-rezeptor

Country Status (3)

Country Link
EP (1) EP1084142A4 (de)
JP (1) JP2002517222A (de)
WO (1) WO1999064452A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005119252A2 (en) 2004-05-26 2005-12-15 Arena Pharmaceuticals, Inc. Modulators of gpr35 for the treatment of metabolic-related disorders
AUPP438598A0 (en) 1998-06-29 1998-07-23 Garvan Institute Of Medical Research NPY-Y7 receptor gene
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2005085867A2 (en) * 2004-02-27 2005-09-15 Pfizer Japan, Inc. Screening method for emulators of neural activity and digestive system using gpr35
DE102004024617A1 (de) * 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
ATE464564T1 (de) * 2004-08-30 2010-04-15 Takeda Pharmaceutical Screening-verfahren
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
CA2890438C (en) 2012-11-13 2022-10-18 Biontech Ag Agents for treatment of claudin expressing cancer diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008155A2 (en) * 1998-08-07 2000-02-17 Incyte Pharmaceuticals, Inc. Human receptor-associated proteins
WO2000023603A2 (en) * 1998-10-21 2000-04-27 Arch Development Corporation Methods of treatment of type 2 diabetes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008155A2 (en) * 1998-08-07 2000-02-17 Incyte Pharmaceuticals, Inc. Human receptor-associated proteins
WO2000023603A2 (en) * 1998-10-21 2000-04-27 Arch Development Corporation Methods of treatment of type 2 diabetes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9964452A1 *

Also Published As

Publication number Publication date
JP2002517222A (ja) 2002-06-18
WO1999064452A1 (en) 1999-12-16
EP1084142A1 (de) 2001-03-21

Similar Documents

Publication Publication Date Title
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
PL345247A1 (en) Retinoid-associated receptor regulators
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
GB9826359D0 (en) Novel receptors
DE60042897D1 (en) Photovervielfacherröhre
IL146151A0 (en) Human-g-protein receptor
DE59904407D1 (en) Chromanderivate
EP1084142A4 (de) Gpr35a-rezeptor
GB9816729D0 (en) Substituted cyclohexylaminopyrimidines
HK1039937A1 (zh) 取代的3-硫代氨基甲酰基吡唑類化合物
EP0973800A4 (de) Neuartiger rezeptor
PL347397A1 (en) Substituted 3-aryl-pyrazoles
DE59900495D1 (en) Multimetalloxidmassen
DE59900471D1 (en) Inchbremseinrichtung
GB9819420D0 (en) Novel receptor
EP1079848A4 (de) Angiostatinrezeptor
HUP0102476A3 (en) Substituted cyclooctadepsipeptides
HK1039335A1 (zh) 取代的苯甲酰基環已二酮類化合物
EP1083909A4 (de) hCEPR REZEPTOR
EP1131335A4 (de) 7tm rezeptor hlwar77
GB9827016D0 (en) Receptor protein
DE59905941D1 (en) Methoximinophenylessigsäureamide
EP1092021A4 (de) Gen des npy-y7 rezeptors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20041202

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7G 01N 33/53 B

Ipc: 7G 01N 33/50 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 16/18 B

Ipc: 7C 12N 5/10 B

Ipc: 7C 07K 14/705 B

Ipc: 7C 12N 15/12 A

17Q First examination report despatched

Effective date: 20071024

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080304